查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1592900

感染監測解決方案市場：按產品、部署和最終用戶 - 2025-2030 年全球預測

Infection Surveillance Solution Market by Product (Services, Software), Deployment (On-Cloud, On-Premise), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年感染監測解決方案市值為7.6847億美元，預計2024年將達到8.6799億美元，複合年成長率為13.36%，到2030年將達到18.4973億美元。

感染監測解決方案 (ISS) 包括旨在監測、預防和控制感染疾病的綜合系統和方法，特別是在醫療保健環境中。這些解決方案包括軟體平台、分析工具和即時資料監控系統。這項需求源自於控制醫療保健相關感染（HAIs）、最佳化抗生素使用和提高病人安全的迫切需要，這在抗藥性病原體和醫院感染增加的推動下極為重要。應用領域包括醫院、門診病人設施和輔助生活設施，使其成為感染預防團隊、流行病學家和醫療保健管理者的重要工具。 ISS 市場的開拓主要是由人們對 HAI 的認知不斷提高、政府對感染控制措施的要求以及醫療基礎設施的持續發展（尤其是在新興市場）所推動的。此外，資料分析中的機器學習和人工智慧等技術進步透過實現更具預測性和個人化的感染控制措施提供了潛在的機會。然而，初始成本高、與現有醫院資訊系統整合的複雜性以及資料隱私問題等限制構成了重大挑戰。此外，新興市場缺乏意識和基礎設施不足正在阻礙市場滲透和成長。開發可與不同醫療 IT 系統無縫整合的可互通平台、利用人工智慧預測分析進行早期感染預警以及利用穿戴式技術進行即時病患監測，存在巨大的創新機會。該市場主要是技術主導的，重點關注醫療保健領域的數位轉型。因此，尋求發展的公司應該投資於增強系統互通性和使用者介面設計的研發，並確保遵守資料保護條例。鑑於世界日益成長的健康問題，這些策略舉措可以使公司成為感染預防技術​​的領導者，推動市場發展並改善公共衛生。

主要市場統計
基準年[2023] 7.6847億美元
預測年份 [2024] 86799萬美元
預測年份 [2030] 1,849.73 百萬美元
複合年成長率（%） 13.36%

市場動態：針對快速發展的感染監測解決方案市場揭示的關鍵市場洞察

供需的動態交互作用正在改變感染監測解決方案市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 老年人口增加和慢性病增加
    • 院內感染 (HAI) 增加
    • 更多採用抗菌藥物管理計劃
  • 市場限制因素
    • 部署感染監測解決方案相關的高成本
  • 市場機會
    • 透過與電子健康記錄整合開發全自動感染監測解決方案系統
    • 雲端基礎的感染監測解決方案迅速崛起
  • 市場挑戰
    • 缺乏熟練的醫療保健 IT 專業人員

波特五力：引領感染監測解決方案市場的策略工具

波特的五力框架是了解感染監控解決方案市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解感染監測解決方案市場的外部影響

外部宏觀環境因素在塑造感染監控解決方案市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解感染監測解決方案市場的競爭格局

對感染監控解決方案市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣感染監測解決方案市場供應商績效評估

FPNV 定位矩陣是評估感染監控解決方案市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃感染監測解決方案市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對感染監控解決方案市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人口老化加劇，慢性病發生率上升
      • 院內感染 (HAI) 盛行率增加
      • 更多地引入抗菌藥物管理計劃
    • 抑制因素
      • 實施感染監測解決方案相關的高成本
    • 機會
      • 開發整合電子健康記錄的全自動感染監測解決方案系統
      • 雲端基礎的感染監測解決方案迅速興起
    • 任務
      • 缺乏熟練的醫療保健 IT 專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章感染監測解決方案市場：依產品

  • 服務
    • 實施服務
    • 產品支援和維護服務
    • 培訓和諮詢服務
  • 軟體
    • 抗菌監測和控制
    • 感染監測
      • 實驗室監測
      • 手術監測和病患監測
    • 疫情管理
      • 檢疫管理
      • 警告潛在的感染傳播
    • 員工健康和合規性

第7章感染監測解決方案市場：依部署

  • 在雲端
  • 本地

第 8 章感染監測解決方案市場：按最終用戶分類

  • 醫院
  • 研究所
  • 長期照護設施

第9章美洲感染監測解決方案市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太感染監測解決方案市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的感染監測解決方案市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Orbis Protect 收購了 Secure Site UK，以進一步加強其安全解決方案和服務產品。
    • 西哈特福德-布魯姆菲爾德衛生區的醫療保健相關感染控制聯盟團隊被評為 NACCHO 感染預防和控制冠軍。
    • 一家美國公司被指定為該 2000 萬英鎊（2406 萬美元）框架的唯一供應商。
    • Foresight Group 已從其 Midlands Engine Investment Fund 向 ReadyGo Diagnostics Limited 追加投資 100 萬英鎊（120 萬美元）。
    • RACGP 發布了新的感染預防和控制指南。
    • 麻省理工學院的化學家開發了用於生物感測的無線電子橫向流動化驗測試。
    • 感染防治線上學習已啟動。
    • Premier 將 PINC AI 臨床監測技術部署到長期照護機構。
    • Bitscope 臨床監測軟體將在 VA 洛杉磯和 VA 拉斯維加斯實施。
  • 戰略分析和建議

公司名單

  • 3M Company
  • Altarum
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • BioVigil Healthcare Systems, Inc.
  • Cardinal Health Inc.
  • CenTrak, Inc.
  • Clinsys, Inc.
  • Conduent, Inc.
  • Datlowe, sro
  • DNV AS
  • Ecolab Inc.
  • Gunnebo Entrance Control Ltd.
  • Health Matrix.
  • Ibhar Technologies Pvt Ltd
  • Inovalon
  • International Business Machines Corporation
  • Medexter Healthcare GmbH
  • Oracle Corporation
  • PointClickCare
  • Premier Inc.
  • RLDatix
  • Securitas Healthcare, LLC.
  • Strategic Solutions Group
  • Thermo Fisher Scientific Inc.
  • Vecna Technologies, Inc.
  • VigiLanz Corporation
  • Vitalacy Inc.
  • Vizzia Technologies
  • Wolters Kluwer NV
Product Code: MRR-43127F727969

The Infection Surveillance Solution Market was valued at USD 768.47 million in 2023, expected to reach USD 867.99 million in 2024, and is projected to grow at a CAGR of 13.36%, to USD 1,849.73 million by 2030.

Infection Surveillance Solutions (ISS) involve comprehensive systems and methodologies designed to monitor, prevent, and manage infections, especially within healthcare settings. These solutions encompass software platforms, analytical tools, and real-time data monitoring systems. Their necessity stems from the urgent need to curtail healthcare-associated infections (HAIs), optimize antibiotic use, and enhance patient safety, which are critical due to increasing drug-resistant pathogens and nosocomial infections. Application areas include hospitals, outpatient facilities, and assisted living environments, serving as instrumental tools for infection prevention teams, epidemiologists, and healthcare administrators. The market for ISS is primarily driven by heightened awareness around HAIs, government mandates for infection control, and the continuous evolution of healthcare infrastructure, particularly in developed regions. Additionally, technological advancements such as machine learning and AI in data analytics offer potential opportunities by enabling more predictive and personalized infection control measures. However, limitations like high initial costs, integration complexities with existing hospital information systems, and data privacy concerns pose significant challenges. Further, a lack of awareness and inadequate infrastructure in developing regions hinder market penetration and growth. The best opportunity for innovation lies in developing interoperable platforms that can seamlessly integrate with diverse health IT systems, adopting AI-enabled predictive analytics for early infection warning, and harnessing wearable technology for real-time patient monitoring. The market is largely technology-driven, with a dynamic focus on digital transformation in healthcare. Thus, businesses aiming for growth should invest in R&D that enhances system interoperability and user interface design, ensuring compliance with data protection regulations. Given the increasing global health concerns, such strategic moves could position a company as a leader in infection prevention technology, driving market evolution and public health improvements.

KEY MARKET STATISTICS
Base Year [2023] USD 768.47 million
Estimated Year [2024] USD 867.99 million
Forecast Year [2030] USD 1,849.73 million
CAGR (%) 13.36%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infection Surveillance Solution Market

The Infection Surveillance Solution Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing geriatric population coupled with increasing incidences of chronic diseases
    • Increasing prevalence of hospital-acquired infections (HAIs)
    • Rising adoption of antimicrobial stewardship programs
  • Market Restraints
    • High cost associated with the deployment of infection surveillance solutions
  • Market Opportunities
    • Development of fully automated infection surveillance solution systems with the integration of electronic medical records
    • Rapid emergence of cloud based infection surveillance solutions
  • Market Challenges
    • Limited availability of skilled healthcare IT professional

Porter's Five Forces: A Strategic Tool for Navigating the Infection Surveillance Solution Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infection Surveillance Solution Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infection Surveillance Solution Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infection Surveillance Solution Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infection Surveillance Solution Market

A detailed market share analysis in the Infection Surveillance Solution Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infection Surveillance Solution Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infection Surveillance Solution Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infection Surveillance Solution Market

A strategic analysis of the Infection Surveillance Solution Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infection Surveillance Solution Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Altarum, Baxter International, Inc., Becton, Dickinson and Company, bioMerieux SA, BioVigil Healthcare Systems, Inc., Cardinal Health Inc., CenTrak, Inc., Clinsys, Inc., Conduent, Inc., Datlowe, s.r.o., DNV AS, Ecolab Inc., Gunnebo Entrance Control Ltd., Health Matrix., Ibhar Technologies Pvt Ltd, Inovalon, International Business Machines Corporation, Medexter Healthcare GmbH, Oracle Corporation, PointClickCare, Premier Inc., RLDatix, Securitas Healthcare, LLC., Strategic Solutions Group, Thermo Fisher Scientific Inc., Vecna Technologies, Inc., VigiLanz Corporation, Vitalacy Inc., Vizzia Technologies, and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the Infection Surveillance Solution Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Services and Software. The Services is further studied across Implementation Services, Product Support & Maintainnace Services, and Training & Consulting Services. The Software is further studied across Antimicrobial Monitoring & Control, Infection Surveillance, Outbreak Management, and Staff Health & Compliance. The Infection Surveillance is further studied across Laboratory surveillance and Surgical surveillance & patient monitoring. The Outbreak Management is further studied across Isolation Management and Potential Outbreak Alert.
  • Based on Deployment, market is studied across On-Cloud and On-Premise.
  • Based on End-User, market is studied across Hospital, Laboratories, and Long-Term Care Facility.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing geriatric population coupled with increasing incidences of chronic diseases
      • 5.1.1.2. Increasing prevalence of hospital-acquired infections (HAIs)
      • 5.1.1.3. Rising adoption of antimicrobial stewardship programs
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the deployment of infection surveillance solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of fully automated infection surveillance solution systems with the integration of electronic medical records
      • 5.1.3.2. Rapid emergence of cloud based infection surveillance solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of skilled healthcare IT professional
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Infection Surveillance Solution Market, by Product

  • 6.1. Introduction
  • 6.2. Services
    • 6.2.1. Implementation Services
    • 6.2.2. Product Support & Maintainnace Services
    • 6.2.3. Training & Consulting Services
  • 6.3. Software
    • 6.3.1. Antimicrobial Monitoring & Control
    • 6.3.2. Infection Surveillance
      • 6.3.2.1. Laboratory surveillance
      • 6.3.2.2. Surgical surveillance & patient monitoring
    • 6.3.3. Outbreak Management
      • 6.3.3.1. Isolation Management
      • 6.3.3.2. Potential Outbreak Alert
    • 6.3.4. Staff Health & Compliance

7. Infection Surveillance Solution Market, by Deployment

  • 7.1. Introduction
  • 7.2. On-Cloud
  • 7.3. On-Premise

8. Infection Surveillance Solution Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospital
  • 8.3. Laboratories
  • 8.4. Long-Term Care Facility

9. Americas Infection Surveillance Solution Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Infection Surveillance Solution Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Infection Surveillance Solution Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Orbis Protect Acquires Secure Site UK to Further Enhance Their Security Solutions & Service Offering.
    • 12.3.2. West Hartford-Bloomfield Health District Coalition Against Healthcare-Acquired Infections Team Recognized as NACCHO Infection Prevention and Control Champion.
    • 12.3.3. American Firm Named as Sole Supplier For £20m (USD 24.06 Million) Framework.
    • 12.3.4. Foresight Group Invests Additional £1 Million (USD 1.20 Million) from the Midlands Engine Investment Fund into ReadyGo Diagnostics Limited.
    • 12.3.5. RACGP Launches New Infection Prevention and Control Guidelines.
    • 12.3.6. MIT Chemists Develop a Wireless Electronic Lateral Flow Assay Test for Biosensing.
    • 12.3.7. Infection Prevention and Control Online Learning Launched.
    • 12.3.8. Premier Brings PINC AI Clinical Surveillance Technology to Long-Term Care Facilities.
    • 12.3.9. Bitscopic's Clinical Surveillance Software to be Implemented at VA Los Angeles and VA Las Vegas.
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Altarum
  • 3. Baxter International, Inc.
  • 4. Becton, Dickinson and Company
  • 5. bioMerieux SA
  • 6. BioVigil Healthcare Systems, Inc.
  • 7. Cardinal Health Inc.
  • 8. CenTrak, Inc.
  • 9. Clinsys, Inc.
  • 10. Conduent, Inc.
  • 11. Datlowe, s.r.o.
  • 12. DNV AS
  • 13. Ecolab Inc.
  • 14. Gunnebo Entrance Control Ltd.
  • 15. Health Matrix.
  • 16. Ibhar Technologies Pvt Ltd
  • 17. Inovalon
  • 18. International Business Machines Corporation
  • 19. Medexter Healthcare GmbH
  • 20. Oracle Corporation
  • 21. PointClickCare
  • 22. Premier Inc.
  • 23. RLDatix
  • 24. Securitas Healthcare, LLC.
  • 25. Strategic Solutions Group
  • 26. Thermo Fisher Scientific Inc.
  • 27. Vecna Technologies, Inc.
  • 28. VigiLanz Corporation
  • 29. Vitalacy Inc.
  • 30. Vizzia Technologies
  • 31. Wolters Kluwer N.V.

LIST OF FIGURES

  • FIGURE 1. INFECTION SURVEILLANCE SOLUTION MARKET RESEARCH PROCESS
  • FIGURE 2. INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INFECTION SURVEILLANCE SOLUTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INFECTION SURVEILLANCE SOLUTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INFECTION SURVEILLANCE SOLUTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INFECTION SURVEILLANCE SOLUTION MARKET DYNAMICS
  • TABLE 7. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY IMPLEMENTATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT SUPPORT & MAINTAINNACE SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ANTIMICROBIAL MONITORING & CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY LABORATORY SURVEILLANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SURGICAL SURVEILLANCE & PATIENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ISOLATION MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY POTENTIAL OUTBREAK ALERT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY STAFF HEALTH & COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY LONG-TERM CARE FACILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)

TA